By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
NA
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Kaviani Breast Disease Institute
2021-01-01
|
Series: | Archives of Breast Cancer |
Subjects: | |
Online Access: | https://www.archbreastcancer.com/index.php/abc/article/view/337 |
id |
doaj-d56149a8c57d401cabfa3b199b0f633c |
---|---|
record_format |
Article |
spelling |
doaj-d56149a8c57d401cabfa3b199b0f633c2021-02-02T21:55:51ZengKaviani Breast Disease InstituteArchives of Breast Cancer2383-04332021-01-0110.32768/abc.2021818-13By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast CancerRichard Love0Department of Computer Science, Marquette University, Milwaukee, WI, USA NA https://www.archbreastcancer.com/index.php/abc/article/view/337Adjuvant therapy Surgical oophorectomyTamoxifenSecondary effects Key metrics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Richard Love |
spellingShingle |
Richard Love By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer Archives of Breast Cancer Adjuvant therapy Surgical oophorectomy Tamoxifen Secondary effects Key metrics |
author_facet |
Richard Love |
author_sort |
Richard Love |
title |
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer |
title_short |
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer |
title_full |
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer |
title_fullStr |
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer |
title_full_unstemmed |
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer |
title_sort |
by the metrics surgical oophorectomy plus tamoxifen is the first adjuvant treatment option for premenopausal women with hormone receptor positive breast cancer |
publisher |
Kaviani Breast Disease Institute |
series |
Archives of Breast Cancer |
issn |
2383-0433 |
publishDate |
2021-01-01 |
description |
NA
|
topic |
Adjuvant therapy Surgical oophorectomy Tamoxifen Secondary effects Key metrics |
url |
https://www.archbreastcancer.com/index.php/abc/article/view/337 |
work_keys_str_mv |
AT richardlove bythemetricssurgicaloophorectomyplustamoxifenisthefirstadjuvanttreatmentoptionforpremenopausalwomenwithhormonereceptorpositivebreastcancer |
_version_ |
1724291324501295104 |